Insider trade

Royalty Pharma (RPRX)Chair sold ~$34K

Christopher Hite, Chair at Royalty Pharma, sold ~$34K of Royalty Pharma shares.

~$34K
Approx. value · 600 sh @ $57.09: 40K
Holds after · shares reported

Traded: Jun 30, 2026
Filed: Jul 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Apr 28, 2026Insider · 1 personInsiders: 2 sales (~$1.7M)
May 6, 2026Company filing · Form 8-K · ResultsReported its results
May 14, 2026Insider · 2 peopleInsiders: 2 sales (~$888K)
May 20, 2026InsiderOfficer sold ~$722K of RPRX shares in the open market
May 22, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
May 26, 2026InsiderCFO sold ~$3.48M of RPRX shares in the open market
Jun 23, 2026Insider · 1 personInsiders: 2 sales (~$8.2M)
Jun 24, 2026InsiderOfficer sold ~$502K of RPRX shares in the open market
Jun 30, 2026 · this disclosureInsiderChair sold ~$34K of RPRX shares in the open market

What came next

Jun 30, 2026Insider · 1 personInsiders: 3 sales (~$7.3M)
Jul 1, 2026InsiderOfficer sold ~$508K of RPRX shares in the open market
Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
Aug 13, 2026Insider · 1 personInsiders: 2 sales (~$646K)
Aug 18, 2026InsiderChair sold ~$6M of RPRX shares in the open market
Sep 22, 2026Insider · 1 personInsiders: 2 sales (~$5.9M)
Sep 28, 2026InsiderOfficer sold ~$239K of RPRX shares in the open market
Oct 5, 2026InsiderOfficer sold ~$236K of RPRX shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Royalty Pharma

For Royalty Pharma, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RPRX page.

Other recent filings by Christopher Hite, EVP & Chairman, Partnering

The full history of Christopher Hite, EVP & Chairman, Partnering is on the profile page.

How this filing works

Other disclosures at Royalty Pharma

Everything OQRO holds on this company is on its RPRX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data